Drugs / Bunazosin
Bunazosin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00130156 | Oct 2005 → Sep 2008 | benign essential hypertension | Eisai Inc. | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bunazosin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00130156 ↗ |
| Known as | Bunazosina | ChEMBL registry synonym — accepted as the source's own label CHEMBL188185 ↗ |
| Known as | Bunazosine | ChEMBL registry synonym — accepted as the source's own label CHEMBL188185 ↗ |
| Known as | Detantol-R | “Patients will be randomized to the add-on treatment with Bunazosin (Detantol-R) 3 mg once-daily after breakfast for a total of eight weeks.” NCT00130156 ↗ |
| Modality | Small molecule | — CHEMBL188185 ↗ |